カテゴリ： QYResearch, 世界, 医療/バイオ

非侵襲的リキッドバイオプシーの世界市場2025年：便検査、尿検査、唾液検査、その他

■ 英語タイトル：Global Non-Invasive Liquid Biopsy Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7514）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7514
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[非侵襲的リキッドバイオプシーの世界市場2025年：便検査、尿検査、唾液検査、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は非侵襲的リキッドバイオプシーのグローバル市場について調査・分析し、世界の非侵襲的リキッドバイオプシー市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（便検査、尿検査、唾液検査、その他）、用途別セグメント分析（病院、研究所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Bio-Techne、Endress+Hauser、Exact Sciences Corporation、Lonza Group AG、MDxHealth、Merck KGaA、MutantDx、Norgen Biotek Corp、Nucleix、Oasis Diagnostics Corporation、OraSure Technologies、PerkinElmer、Predicine、Qiagen、Thermo Fisher Scientific、Zymo Research Corporationなどが含まれています。非侵襲的リキッドバイオプシーのグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、非侵襲的リキッドバイオプシー市場規模を算出する際に考慮しました。

・非侵襲的リキッドバイオプシー市場の概要
- 非侵襲的リキッドバイオプシーの種類別セグメント
- 世界の非侵襲的リキッドバイオプシー市場規模：タイプ別分析（便検査、尿検査、唾液検査、その他）
- 非侵襲的リキッドバイオプシーの用途別セグメント
- 世界の非侵襲的リキッドバイオプシー市場規模：用途別分析（病院、研究所、その他）
- 世界の非侵襲的リキッドバイオプシー市場規模予測（2020年-2031年）

・非侵襲的リキッドバイオプシー市場の成長トレンド
- 非侵襲的リキッドバイオプシーの地域別市場規模（2020年-2031年）
- 非侵襲的リキッドバイオプシー市場ダイナミクス
- 非侵襲的リキッドバイオプシーの業界動向
- 非侵襲的リキッドバイオプシー市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：便検査、尿検査、唾液検査、その他
- 世界の非侵襲的リキッドバイオプシーのタイプ別市場規模（2020年-2025年）
- 世界の非侵襲的リキッドバイオプシーのタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、研究所、その他
- 世界の非侵襲的リキッドバイオプシーの用途別市場規模（2020年-2025年）
- 世界の非侵襲的リキッドバイオプシーの用途別市場規模（2024年-2029年）

・非侵襲的リキッドバイオプシーの地域別市場規模
- 北米の非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- 米国の非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- ヨーロッパの非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- アジア太平洋の非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- 中国の非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- 日本の非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- 韓国の非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- インドの非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- オーストラリアの非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- 中南米の非侵襲的リキッドバイオプシー市場規模（2020年-2031年）
- 中東・アフリカの非侵襲的リキッドバイオプシー市場規模（2020年-2031年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Bio-Techne、Endress+Hauser、Exact Sciences Corporation、Lonza Group AG、MDxHealth、Merck KGaA、MutantDx、Norgen Biotek Corp、Nucleix、Oasis Diagnostics Corporation、OraSure Technologies、PerkinElmer、Predicine、Qiagen、Thermo Fisher Scientific、Zymo Research Corporation

・アナリストの観点/結論

・調査手法と情報源

Non-invasive liquid biopsy is to analyze and diagnose diseases such as cancer through blood or urine and other body fluids. At present, the main application area of liquid biopsy is the blood detection of tumors, that is, the use of blood to indicate tumor development and drug resistance and other information to guide individualized and precise treatment. Compared with existing tumor detection methods, liquid biopsy is non-invasive, can be detected frequently and repeatedly, and has rapid response capabilities. It has significant advantages and has great potential for application development.
Highlights
The global Non-Invasive Liquid Biopsy market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Non-Invasive Liquid Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non-Invasive Liquid Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Non-Invasive Liquid Biopsy in Hospital is estimated to increase from $ million in 2023 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global companies of Non-Invasive Liquid Biopsy include Bio-Techne, Endress+Hauser, Exact Sciences Corporation, Lonza Group AG, MDxHealth, Merck KGaA, MutantDx, Norgen Biotek Corp and Nucleix, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-Invasive Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Liquid Biopsy.
The Non-Invasive Liquid Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Invasive Liquid Biopsy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Invasive Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bio-Techne
Endress+Hauser
Exact Sciences Corporation
Lonza Group AG
MDxHealth
Merck KGaA
MutantDx
Norgen Biotek Corp
Nucleix
Oasis Diagnostics Corporation
OraSure Technologies
PerkinElmer
Predicine
Qiagen
Thermo Fisher Scientific
Zymo Research Corporation
Segment by Type
Stool Test
Urine Test
Saliva Test
Others
Segment by Application
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Invasive Liquid Biopsy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Invasive Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stool Test
1.2.3 Urine Test
1.2.4 Saliva Test
1.2.5 Others
1.3 Market by Application
1.3.1 Global Non-Invasive Liquid Biopsy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Invasive Liquid Biopsy Market Perspective (2020-2031)
2.2 Non-Invasive Liquid Biopsy Growth Trends by Region
2.2.1 Global Non-Invasive Liquid Biopsy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Non-Invasive Liquid Biopsy Historic Market Size by Region (2020-2025)
2.2.3 Non-Invasive Liquid Biopsy Forecasted Market Size by Region (2026-2031)
2.3 Non-Invasive Liquid Biopsy Market Dynamics
2.3.1 Non-Invasive Liquid Biopsy Industry Trends
2.3.2 Non-Invasive Liquid Biopsy Market Drivers
2.3.3 Non-Invasive Liquid Biopsy Market Challenges
2.3.4 Non-Invasive Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Invasive Liquid Biopsy Players by Revenue
3.1.1 Global Top Non-Invasive Liquid Biopsy Players by Revenue (2020-2025)
3.1.2 Global Non-Invasive Liquid Biopsy Revenue Market Share by Players (2020-2025)
3.2 Global Non-Invasive Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Invasive Liquid Biopsy Revenue
3.4 Global Non-Invasive Liquid Biopsy Market Concentration Ratio
3.4.1 Global Non-Invasive Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Liquid Biopsy Revenue in 2022
3.5 Non-Invasive Liquid Biopsy Key Players Head office and Area Served
3.6 Key Players Non-Invasive Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Non-Invasive Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Invasive Liquid Biopsy Breakdown Data by Type
4.1 Global Non-Invasive Liquid Biopsy Historic Market Size by Type (2020-2025)
4.2 Global Non-Invasive Liquid Biopsy Forecasted Market Size by Type (2026-2031)
5 Non-Invasive Liquid Biopsy Breakdown Data by Application
5.1 Global Non-Invasive Liquid Biopsy Historic Market Size by Application (2020-2025)
5.2 Global Non-Invasive Liquid Biopsy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Non-Invasive Liquid Biopsy Market Size (2020-2031)
6.2 North America Non-Invasive Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Non-Invasive Liquid Biopsy Market Size by Country (2020-2025)
6.4 North America Non-Invasive Liquid Biopsy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Invasive Liquid Biopsy Market Size (2020-2031)
7.2 Europe Non-Invasive Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Non-Invasive Liquid Biopsy Market Size by Country (2020-2025)
7.4 Europe Non-Invasive Liquid Biopsy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Invasive Liquid Biopsy Market Size (2020-2031)
8.2 Asia-Pacific Non-Invasive Liquid Biopsy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2020-2025)
8.4 Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Invasive Liquid Biopsy Market Size (2020-2031)
9.2 Latin America Non-Invasive Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Non-Invasive Liquid Biopsy Market Size by Country (2020-2025)
9.4 Latin America Non-Invasive Liquid Biopsy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Invasive Liquid Biopsy Market Size (2020-2031)
10.2 Middle East & Africa Non-Invasive Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2020-2025)
10.4 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne
11.1.1 Bio-Techne Company Detail
11.1.2 Bio-Techne Business Overview
11.1.3 Bio-Techne Non-Invasive Liquid Biopsy Introduction
11.1.4 Bio-Techne Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.1.5 Bio-Techne Recent Development
11.2 Endress+Hauser
11.2.1 Endress+Hauser Company Detail
11.2.2 Endress+Hauser Business Overview
11.2.3 Endress+Hauser Non-Invasive Liquid Biopsy Introduction
11.2.4 Endress+Hauser Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.2.5 Endress+Hauser Recent Development
11.3 Exact Sciences Corporation
11.3.1 Exact Sciences Corporation Company Detail
11.3.2 Exact Sciences Corporation Business Overview
11.3.3 Exact Sciences Corporation Non-Invasive Liquid Biopsy Introduction
11.3.4 Exact Sciences Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.3.5 Exact Sciences Corporation Recent Development
11.4 Lonza Group AG
11.4.1 Lonza Group AG Company Detail
11.4.2 Lonza Group AG Business Overview
11.4.3 Lonza Group AG Non-Invasive Liquid Biopsy Introduction
11.4.4 Lonza Group AG Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.4.5 Lonza Group AG Recent Development
11.5 MDxHealth
11.5.1 MDxHealth Company Detail
11.5.2 MDxHealth Business Overview
11.5.3 MDxHealth Non-Invasive Liquid Biopsy Introduction
11.5.4 MDxHealth Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.5.5 MDxHealth Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Non-Invasive Liquid Biopsy Introduction
11.6.4 Merck KGaA Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.6.5 Merck KGaA Recent Development
11.7 MutantDx
11.7.1 MutantDx Company Detail
11.7.2 MutantDx Business Overview
11.7.3 MutantDx Non-Invasive Liquid Biopsy Introduction
11.7.4 MutantDx Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.7.5 MutantDx Recent Development
11.8 Norgen Biotek Corp
11.8.1 Norgen Biotek Corp Company Detail
11.8.2 Norgen Biotek Corp Business Overview
11.8.3 Norgen Biotek Corp Non-Invasive Liquid Biopsy Introduction
11.8.4 Norgen Biotek Corp Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.8.5 Norgen Biotek Corp Recent Development
11.9 Nucleix
11.9.1 Nucleix Company Detail
11.9.2 Nucleix Business Overview
11.9.3 Nucleix Non-Invasive Liquid Biopsy Introduction
11.9.4 Nucleix Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.9.5 Nucleix Recent Development
11.10 Oasis Diagnostics Corporation
11.10.1 Oasis Diagnostics Corporation Company Detail
11.10.2 Oasis Diagnostics Corporation Business Overview
11.10.3 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Introduction
11.10.4 Oasis Diagnostics Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.10.5 Oasis Diagnostics Corporation Recent Development
11.11 OraSure Technologies
11.11.1 OraSure Technologies Company Detail
11.11.2 OraSure Technologies Business Overview
11.11.3 OraSure Technologies Non-Invasive Liquid Biopsy Introduction
11.11.4 OraSure Technologies Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.11.5 OraSure Technologies Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Detail
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Non-Invasive Liquid Biopsy Introduction
11.12.4 PerkinElmer Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.12.5 PerkinElmer Recent Development
11.13 Predicine
11.13.1 Predicine Company Detail
11.13.2 Predicine Business Overview
11.13.3 Predicine Non-Invasive Liquid Biopsy Introduction
11.13.4 Predicine Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.13.5 Predicine Recent Development
11.14 Qiagen
11.14.1 Qiagen Company Detail
11.14.2 Qiagen Business Overview
11.14.3 Qiagen Non-Invasive Liquid Biopsy Introduction
11.14.4 Qiagen Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.14.5 Qiagen Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Detail
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Introduction
11.15.4 Thermo Fisher Scientific Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.15.5 Thermo Fisher Scientific Recent Development
11.16 Zymo Research Corporation
11.16.1 Zymo Research Corporation Company Detail
11.16.2 Zymo Research Corporation Business Overview
11.16.3 Zymo Research Corporation Non-Invasive Liquid Biopsy Introduction
11.16.4 Zymo Research Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025)
11.16.5 Zymo Research Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Non-Invasive Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Stool Test
Table 3. Key Players of Urine Test
Table 4. Key Players of Saliva Test
Table 5. Key Players of Others
Table 6. Global Non-Invasive Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Non-Invasive Liquid Biopsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Non-Invasive Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Non-Invasive Liquid Biopsy Market Share by Region (2020-2025)
Table 10. Global Non-Invasive Liquid Biopsy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Non-Invasive Liquid Biopsy Market Share by Region (2026-2031)
Table 12. Non-Invasive Liquid Biopsy Market Trends
Table 13. Non-Invasive Liquid Biopsy Market Drivers
Table 14. Non-Invasive Liquid Biopsy Market Challenges
Table 15. Non-Invasive Liquid Biopsy Market Restraints
Table 16. Global Non-Invasive Liquid Biopsy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Non-Invasive Liquid Biopsy Market Share by Players (2020-2025)
Table 18. Global Top Non-Invasive Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Liquid Biopsy as of 2022)
Table 19. Ranking of Global Top Non-Invasive Liquid Biopsy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Non-Invasive Liquid Biopsy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Non-Invasive Liquid Biopsy Product Solution and Service
Table 23. Date of Enter into Non-Invasive Liquid Biopsy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-Invasive Liquid Biopsy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Non-Invasive Liquid Biopsy Revenue Market Share by Type (2020-2025)
Table 27. Global Non-Invasive Liquid Biopsy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Non-Invasive Liquid Biopsy Revenue Market Share by Type (2026-2031)
Table 29. Global Non-Invasive Liquid Biopsy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Non-Invasive Liquid Biopsy Revenue Market Share by Application (2020-2025)
Table 31. Global Non-Invasive Liquid Biopsy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Non-Invasive Liquid Biopsy Revenue Market Share by Application (2026-2031)
Table 33. North America Non-Invasive Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Non-Invasive Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Non-Invasive Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Non-Invasive Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Non-Invasive Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Non-Invasive Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Non-Invasive Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Non-Invasive Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Non-Invasive Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Non-Invasive Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Non-Invasive Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 48. Bio-Techne Company Detail
Table 49. Bio-Techne Business Overview
Table 50. Bio-Techne Non-Invasive Liquid Biopsy Product
Table 51. Bio-Techne Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 52. Bio-Techne Recent Development
Table 53. Endress+Hauser Company Detail
Table 54. Endress+Hauser Business Overview
Table 55. Endress+Hauser Non-Invasive Liquid Biopsy Product
Table 56. Endress+Hauser Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 57. Endress+Hauser Recent Development
Table 58. Exact Sciences Corporation Company Detail
Table 59. Exact Sciences Corporation Business Overview
Table 60. Exact Sciences Corporation Non-Invasive Liquid Biopsy Product
Table 61. Exact Sciences Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 62. Exact Sciences Corporation Recent Development
Table 63. Lonza Group AG Company Detail
Table 64. Lonza Group AG Business Overview
Table 65. Lonza Group AG Non-Invasive Liquid Biopsy Product
Table 66. Lonza Group AG Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 67. Lonza Group AG Recent Development
Table 68. MDxHealth Company Detail
Table 69. MDxHealth Business Overview
Table 70. MDxHealth Non-Invasive Liquid Biopsy Product
Table 71. MDxHealth Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 72. MDxHealth Recent Development
Table 73. Merck KGaA Company Detail
Table 74. Merck KGaA Business Overview
Table 75. Merck KGaA Non-Invasive Liquid Biopsy Product
Table 76. Merck KGaA Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 77. Merck KGaA Recent Development
Table 78. MutantDx Company Detail
Table 79. MutantDx Business Overview
Table 80. MutantDx Non-Invasive Liquid Biopsy Product
Table 81. MutantDx Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 82. MutantDx Recent Development
Table 83. Norgen Biotek Corp Company Detail
Table 84. Norgen Biotek Corp Business Overview
Table 85. Norgen Biotek Corp Non-Invasive Liquid Biopsy Product
Table 86. Norgen Biotek Corp Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 87. Norgen Biotek Corp Recent Development
Table 88. Nucleix Company Detail
Table 89. Nucleix Business Overview
Table 90. Nucleix Non-Invasive Liquid Biopsy Product
Table 91. Nucleix Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 92. Nucleix Recent Development
Table 93. Oasis Diagnostics Corporation Company Detail
Table 94. Oasis Diagnostics Corporation Business Overview
Table 95. Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Product
Table 96. Oasis Diagnostics Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 97. Oasis Diagnostics Corporation Recent Development
Table 98. OraSure Technologies Company Detail
Table 99. OraSure Technologies Business Overview
Table 100. OraSure Technologies Non-Invasive Liquid Biopsy Product
Table 101. OraSure Technologies Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 102. OraSure Technologies Recent Development
Table 103. PerkinElmer Company Detail
Table 104. PerkinElmer Business Overview
Table 105. PerkinElmer Non-Invasive Liquid Biopsy Product
Table 106. PerkinElmer Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 107. PerkinElmer Recent Development
Table 108. Predicine Company Detail
Table 109. Predicine Business Overview
Table 110. Predicine Non-Invasive Liquid Biopsy Product
Table 111. Predicine Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 112. Predicine Recent Development
Table 113. Qiagen Company Detail
Table 114. Qiagen Business Overview
Table 115. Qiagen Non-Invasive Liquid Biopsy Product
Table 116. Qiagen Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 117. Qiagen Recent Development
Table 118. Thermo Fisher Scientific Company Detail
Table 119. Thermo Fisher Scientific Business Overview
Table 120. Thermo Fisher Scientific Non-Invasive Liquid Biopsy Product
Table 121. Thermo Fisher Scientific Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 122. Thermo Fisher Scientific Recent Development
Table 123. Zymo Research Corporation Company Detail
Table 124. Zymo Research Corporation Business Overview
Table 125. Zymo Research Corporation Non-Invasive Liquid Biopsy Product
Table 126. Zymo Research Corporation Revenue in Non-Invasive Liquid Biopsy Business (2020-2025) & (US$ Million)
Table 127. Zymo Research Corporation Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Invasive Liquid Biopsy Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 2. Global Non-Invasive Liquid Biopsy Market Share by Type: 2022 VS 2029
Figure 3. Stool Test Features
Figure 4. Urine Test Features
Figure 5. Saliva Test Features
Figure 6. Others Features
Figure 7. Global Non-Invasive Liquid Biopsy Market Size Comparison by Application (2025-2031) & (US$ Million)
Figure 8. Global Non-Invasive Liquid Biopsy Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Others Case Studies
Figure 12. Non-Invasive Liquid Biopsy Report Years Considered
Figure 13. Global Non-Invasive Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Non-Invasive Liquid Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Non-Invasive Liquid Biopsy Market Share by Region: 2022 VS 2029
Figure 16. Global Non-Invasive Liquid Biopsy Market Share by Players in 2024
Figure 17. Global Top Non-Invasive Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Liquid Biopsy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Non-Invasive Liquid Biopsy Revenue in 2024
Figure 19. North America Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Non-Invasive Liquid Biopsy Market Share by Country (2020-2031)
Figure 21. United States Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Non-Invasive Liquid Biopsy Market Share by Country (2020-2031)
Figure 25. Germany Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Non-Invasive Liquid Biopsy Market Share by Region (2020-2031)
Figure 33. China Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Non-Invasive Liquid Biopsy Market Share by Country (2020-2031)
Figure 41. Mexico Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Non-Invasive Liquid Biopsy Market Share by Country (2020-2031)
Figure 45. Turkey Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Non-Invasive Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bio-Techne Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 48. Endress+Hauser Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 49. Exact Sciences Corporation Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 50. Lonza Group AG Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 51. MDxHealth Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 52. Merck KGaA Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 53. MutantDx Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 54. Norgen Biotek Corp Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 55. Nucleix Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 56. Oasis Diagnostics Corporation Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 57. OraSure Technologies Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 58. PerkinElmer Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 59. Predicine Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 60. Qiagen Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 62. Zymo Research Corporation Revenue Growth Rate in Non-Invasive Liquid Biopsy Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

※参考情報

非侵襲的リキッドバイオプシーは、近年の医学研究や診断技術の進展により、注目を集めている新しい診断手法です。この技術は、患者に対して侵襲的な手法を用いることなく、血液やその他の体液中に存在するバイオマーカーを解析することによって、がんや他の疾患の診断やモニタリングを行う方法です。リキッドバイオプシーは、従来の組織生検と比べていくつかの利点を持っています。

まず、リキッドバイオプシーの大きな特徴の一つは、その非侵襲性です。従来の生検は、腫瘍組織を直接取り出す必要があり、これには手術や針生検といった侵襲的な技術が用いられます。これに対し、リキッドバイオプシーは、血液や尿、唾液などの体液を採取するだけで済むため、患者に対する負担が大幅に軽減されます。この非侵襲性は、特に高齢者や体力のない患者にとっては大きな利点となります。

次に、リキッドバイオプシーのもう一つの特徴は、迅速な結果が得られることです。従来の生検では、組織を取り出し、病理学的に分析する過程が必要ですが、リキッドバイオプシーでは体液を採取した後、比較的短時間で結果を得ることが可能です。これにより、診断が迅速に行われ、適切な治療が早期に始められる可能性が高まります。

リキッドバイオプシーにはいくつかの種類があります。最も一般的なものとしては、循環腫瘍細胞（CTC）の検出、循環腫瘍DNA（ctDNA）の解析、エクソソームの分析などが挙げられます。CTCは、腫瘍から血液中に放出されたがん細胞であり、これを検出することによりがんの存在を確認することができます。一方、ctDNAは、腫瘍から放出されたDNA断片を指し、これを解析することで腫瘍の遺伝子変異についての情報を得ることができます。また、エクソソームは細胞から分泌される小さな膜構造であり、ここに含まれるRNAやタンパク質は、新たなバイオマーカーとして注目されています。

リキッドバイオプシーの主な用途は、主にがんの早期発見、診断、治療効果のモニタリング、再発のチェックなどです。特にがん患者に対しては、治療経過中の変化をリアルタイムで把握するために非常に有用です。また、治療の選択においても、ctDNA分析を通じて特定の治療薬に対する反応性を予測することが可能であり、個別化医療の推進にも寄与しています。

さらに、リキッドバイオプシーは、がんだけでなく、他の疾患の診断にも応用可能です。例えば心血管疾患や神経変性疾患などにおいても、体液中の特定のバイオマーカーを検出することによって、早期診断や病態の評価が行われることが期待されています。

このようなリキッドバイオプシーの発展には、いくつかの関連技術が大きく寄与しています。例えば、高感度の分子解析技術や次世代シーケンシング（NGS）、ナノテクノロジーなどが挙げられます。これらの技術の進歩により、血液中の微量なバイオマーカーの検出が可能になり、リキッドバイオプシーの信頼性が向上しています。

リキッドバイオプシーは、その可能性から多くの研究が進められており、臨床応用も少しずつ広がっています。しかし、まだ多くの課題も残されています。例えば、阳性と偽阴性の結果が生じる可能性、異なる患者間でのバイオマーカーの変動、そして、解析方法の標準化や品質管理などです。これらの課題を克服するためには、さらなる研究と技術開発が必要です。

以上のように、非侵襲的リキッドバイオプシーは、現代医学における重要な進展を示す技術であり、その可能性は将来の医療において大きな影響を与えると期待されています。患者の負担を軽減し、より早期の診断と治療を実現するための有力な手段として、さらなる発展と普及が求められています。リキッドバイオプシーがもたらす新しい診断の形は、今後の医療の風景を大きく変える可能性を秘めています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • がん診断用リキッドバイオプシーのグローバル市場展望 2023年-2029年：血液検査、尿検査、唾液検査
  • 愛犬DNA検査の世界市場2025年：唾液検査、便検査
  • 世界の乱用薬物診断キット市場2025年：企業・地域・タイプ・用途別予測（～2031年）
  • 乱用薬物検査用試薬の世界市場2025-2031：尿検査、唾液検査、血液検査、毛髪・汗検査、その他
  • 乱用薬物検査用試薬キットの世界市場2025-2031：尿検査、唾液検査、血液検査、毛髪・汗検査、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7514 )"非侵襲的リキッドバイオプシーの世界市場2025年：便検査、尿検査、唾液検査、その他" (英文：Global Non-Invasive Liquid Biopsy Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。